Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors

24 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Syndromes and Imprinting
Share to Neuroblastoma Research and Treatments
Share to Neuroendocrine Tumor Research Advances

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35882361
DOI: 10.1016/j.trsl.2022.07.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsPMID 35882361Read ↗

Spliceosomic dysregulation unveils <i>NOVA1</i> as an actionable therapeutic target in pancreatic neuroendocrine tumorsSemantic proximity Read ↗

An integrative RNA spliceosomic landscape of pancreatic neuroendocrine tumors unveils novel clinicomolecular associationsSemantic proximity Read ↗

Dysregulation of CELF4 splicing factor in pancreatic neuroendocrine tumors enhances aggressiveness and alters mTOR pathway and everolimus responseSemantic proximity Read ↗

Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseSemantic proximity Read ↗

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient PrognosisSemantic proximity Read ↗

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discoverySemantic proximity Read ↗

NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biologySemantic proximity Read ↗

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.Semantic proximity Read ↗

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discoverySemantic proximity Read ↗

PCF11 links alternative polyadenylation to formation and spontaneous regression of neuroblastomaSemantic proximity Read ↗

Spliceosomic profiling in pheochromocytomas and paragangliomas reveals alterations associated with clinico-molecular features and unveils RBM39 as a therapeutic targetSemantic proximity Read ↗

A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.